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Osteolytic primary bone lymphoma in the multiple bones
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Abstract : Primary non-Hodgkin bone lymphoma (PBL) can involve solitary or multiple destructive bone lesions 
such as those of the femur or pelvis humerus, and some cases have osteolytic lesions. PBL is a rare disease in 
adults. Thus, PBL is rarely considered a differential diagnosis of the osteolytic tumor. In addition, PBL can be un-
derdiagnosed because patients do not experience symptoms or show objective abnormalities in the early stage. 
Here, we reported an elderly patient with PBL in multiple bones, including the cranial and femoral bones that 
were fractured due to falling. J. Med. Invest. 66 : 347-350, August, 2019
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INTRODUCTION
 
Primary non-Hodgkin bone lymphoma (PBL) is a rare dis-
ease that accounts for < 2% of all lymphomas in adults (1). PBL 
is estimated to account for 3%–7% of primary bone tumors and 
3%–5% of all extranodal non-Hodgkin lymphomas (2). PBL can 
involve solitary or multiple destructive bone lesions such as 
those of the femur or pelvis humerus, and some cases have os-
teolytic lesions. However, PBL in the cranial vault is extremely 
rare (3). PBL is rarely considered a differential diagnosis of the 
osteolytic tumor. PBL, especially diffuse large B-cell lympho-
ma (DLBCL), exhibits a better response rate for therapy and 
better prognosis if treated early with chemotherapy or radio-
therapy than primary nodal or extranodal DLBCL at other 
sites (4). Thus, accurate early diagnosis is crucial for treatment. 
However, PBL can be underdiagnosed because patients do not 
experience symptoms or show objective abnormalities in the 
early stage.
Here, we reported an elderly patient with PBL in multiple 
bones, including the cranial and femoral bones that were frac-
tured due to falling. 
CASE
An 89-year-old woman presented to our hospital because of 
pain in her right hip after falling. She had severe aortic valve 
stenosis without symptoms. No abnormal neurological and ob-
jective findings on the head were noted. Computed tomography 
(CT) revealed that her right femoral shaft was completely broken 
and that her thin bone cortex was filled with a high-intensity 
tumor at the site of fracture ; osteolytic tumors were also noted 
in the bilateral scapula and lumbar spine bones (Figure 1A, B, 
C, D, E). Whole-body bone scintigram showed accumulation of 
technetium-99m-methylene-diphosphonate (MDP) in the head, 
shoulders, lumbar spine bones, and right femur (Figure 1F) ; this 
indicated that the fracture in her fragile femur was a pathologi-
cal fracture caused by tumor invasion and induced by the trauma 
of falling. She received skeletal traction of the right leg, followed 
by transcatheter aortic valve implantation before the operation 
of the fracture, which was successful. Her broken femoral shaft 
was fixed with a nail device. After the operation for the fracture, 
she experienced drowsiness without any focal neurological signs. 
Head CT showed an osteolytic tumor on the right temporal and 
left back of the head (Figure 2 A, B, C, D). The head tumor was 
mildly tender and overlaid by healthy skin. T1- (Figure 2E) and 
T2-weighted (Figure 2F) magnetic resonance images showed 
iso-intensity and low intensity of the tumor, respectively, and 
the dura structure was maintained. A CT image of the whole 
body showed neither lymphadenopathy nor any evidence of sys-
temic involvement and pathological fracture. Blood examination 
results revealed elevated ALP, LDH, and soluble interleukin-2 
receptor levels at 423 IU/L, 400 IU/L, and 5490 U/mL (upper 
limit < 519 pmol/L), respectively. Decreased serum total protein 
and albumin levels of 5.9 g/dL and 2.9 g/dL, respectively, were 
noted, with no M-protein (IgG 903 mg/dL, IgA 200 mg/dL, IgM 
38 mg/dL, kappa 18 mg/dL, or lamda 78 mg/dL). No monoclonal 
protein was detected by protein electrophoresis of the serum and 
urine. Normocalcemia (albumin-adjusted calcium 9.6 mg/dL) 
with increased parathyroid hormone-related protein-C levels at 
6.5 pmol/L (upper limit < 1.1 pmol/L) were also noted. Increased 
bone markers of type I collagen carboxyterminal telopeptide 
(ICTP) of 20 ng/mL (upper limit < 4.5 ng/mL), tartrate-resistant 
acid phosphatase isoform 5b (TRACP 5b) of 534 mU/dL (upper 
limit 420 mU/dL), and urinary deoxypyridinoline of 79 nmol/
mM・creatinine (upper limit < 7.6 nmol/mM・creatinine) were 
detected, although bone-APL was within normal limits of 20.3 
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Figure 1.　Computed tomography showing fracture of the right femoral shaft (A : arrow), the thin bone cortex (B : arrow) 
filled with a high-intensity tumor (C : arrow) at the fracture site, and osteolytic tumors in the bilateral scapula (D: arrow) 
and lumbar spine bones (E : arrow). Whole-body bone scintigram showing accumulation of technetium-99m-methylene-
diphosphonate in the head, shoulders, lumbar spine bones, and right femur (F).
Figure 2.　Computed tomography showing osteolytic tumors in the right temporal bone, left occipital bone (A, B, C), and 
sphenoid bone (D : arrow). T1-weighted (E) and T2-weighted magnetic resonance imaging (F) showing iso-intensity and low 
intensity of the tumor, respectively.
349The Journal of Medical Investigation   Vol. 66  August  2019
μg/L (upper limit < 22.6 μg/L). Serological test results were 
negative for Epstein-Barr (EB) virus early antigen (EBEA) an-
tibody (IgG) and anti-viral capsid antigen (VCA) IgM and were 
positive for EB virus nuclear antigen IgG and anti-VCA IgG, 
indicating that the patient was infected with EB virus, although 
PCR of EB virus-DNA with the peripheral blood sample was 
not performed. Biopsy of the right temporal soft tissue revealed 
diffuse growth pattern with large cells (Figure 3A) and positiv-
ity for CD20 (Figure 3B), a B-cell marker ; B-cell lymphoma 2 
(BCL-2), an anti-apoptosis factor regulating B-cell development 
and differentiation (Figure 3C). Furthermore, multiple myeloma 
oncogene 1 (MUM-1) (Figure 3D) and negativity for CD3, CD5, 
CD10, CD30, and PD-L1 were noted. The tumor cells included 
Ki-67-positive cells with a Ki labeling index of 80% (Figure 3E), 
indicating highly proliferative potential. In situ hybridization 
of small RNAs of EB virus showed positive cells for EB virus 
infection (Figure 3F). Bone marrow aspiration and bone mar-
row biopsy were not performed. The lesion was localized in the 
bones ; thus, we diagnosed her as having PBL of EBV-positive 
DLBCL of the elderly. Clinical stage of the patient was IV EB 
with a B-symptom of weight loss. The international prognostic 
index was 5, indicating a high risk. The best supportive care 
rather than chemotherapy or radiation therapy was selected, and 
her general condition worsened after the successful operation 
of the femoral fracture. The level of ALP increased to 661 IU/L 
from 571 IU/L during the course, indicating progression of bone 
disease. She died 9 weeks after admission.
DISCUSSION
The differential diagnosis of the osteolytic lesion includes 
secondary bone involvement of the systemic lymphoma, bone 
metastasis from neoplasm, and multiple myeloma. The patient 
was infected with EB virus, and thus, the differential diagnosis 
of EB-related malignancy also included Hodgkin lymphoma and 
Burkitt lymphoma. Imaging studies, including CT and scintig-
raphy, revealed no primary lesion of the malignant tumor, and 
blood examination and results showed no evidence of multiple 
myeloma. In addition, tumor cells were negative for CD138, indi-
cating no differentiation of plasma cells. Immunohistochemistry 
for light chain kappa and lambda staining showed no dominancy 
for either immunoglobulin. Thus, we excluded CD20-positive 
myeloma. Histopathological analysis showed no presence of 
Reed-Sternberg cells and no appearance of a “starry-sky” pat-
tern. Immunophenotype analysis distinguished DLBCL from 
Hodgkin lymphoma and Burkitt lymphoma. Thus, we diagnosed 
her as PBL of EBV-positive DLBCL of the elderly.
T2-weighted MR imaging characteristics of primary lym-
phoma of bone vary and do not seem to be a simple reflection of 
histologic findings of lymphoma (5). In this case, the intensity of 
tumorous lesions was low in T2-weighted MRI. MRI of DLBCL 
with a high nuclear/cytoplasm ratio and hypercellularity could 
cause decreased extracellular fluid concentration and small 
intratumoral edema which results in low signal on t2-weighted 
images (6).
The precise mechanism of osteolysis remains unclear ; how-
ever, the increased expression of osteoclast-activating factors, 
Figure 3.　Hematoxylin and eosin staining (A) of the biopsy obtained from the head tumor showing diffuse growth 
patterns with large cells. Immunohistochemical analysis showing positive results for CD20 (B), BCL-2 (C), MUM-1 (D), 
and high Ki-67 labeling index (E). In situ hybridization of the small RNAs of EB virus showing positive cells for EB 
virus infection (F) (Barr : 100 μm).
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including MIP-1α, MIP-1β, and RANKL, was observed in the 
RNA derived from the patient’s lymphoma cells. In addition, 
increased protein levels of RANKL and osteoprotegerin, a key 
regulator of osteoclastogenesis, from the patient’s lymphoma 
cells were sharply decreased after the chemotherapy (7, 8). Thus, 
the secretion of osteoclast-activating factors by tumor cells (and/
or bone marrow stromal cells) might be involved in the mecha-
nism of osteolysis in some malignant lymphoma cases (9).
Anthracycline-based chemotherapy and radiation therapy are 
recommended for treating PBL (4). The destructive bone involve-
ment in the cranial vault could be regenerated after therapy 
(10). However, we did not recommend such aggressive therapies, 
but suggested best supportive care to our patient because of her 
older age. 
The prognosis of PBL is relatively better than that of other 
lymphoma types (4). Patients with advanced-stage DLBCL and 
skeletal involvement show a 65% complete remission rate (11), 
with 5-year progression-free and overall survival rates of 54% 
and 59%, respectively (12), and bone involvement does not seem 
to be an adverse prognostic factor (4). However, her general con-
dition progressively worsened after the operation of the fracture. 
High proliferative potentials with high Ki-67 labeling index 
might be involved in her progressive poor general condition, 
which was different from gradual proliferative tumors, such as 
multiple myeloma.
Although the patient visited several clinics for medical prob-
lems, including common cold and aortic valve stenosis, the head 
tumor was not detected. Furthermore, PBL can be underdi-
agnosed because skull tumors may be covered by hair. Little 
symptoms are exhibited because the dura structure was main-
tained and brain invasion by the tumor is rare (13). Thus, careful 
inspection and palpation of the head, especially during the first 
visit, are essential even when patients have no head complaints 
in order to make an early diagnosis. In addition, osteolytic PBL 
should be included as a differential diagnosis in cases of femoral 
shaft fractures, even if these fractures occur after falling.
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